Imatinib has adverse effect on growth in children with chronic myeloid leukemia
Author:
Funder
The Max Foundation
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.23389/fullpdf
Reference23 articles.
1. Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?;Suttorp;Biol Blood Marrow Transplant,2011
2. Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT;Suttorp;Bone Marrow Transplant,2008
3. Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: Does it really matter?;Goldman;Leuk Lymphoma,2006
4. Treatment of pediatric chronic myeloid leukemia in the year 2010: Use of tyrosine kinase inhibitors and stem-cell transplantation;Suttorp;Hematol Am Soc Hematol Educ Program,2010
5. Benefits of global partnerships to facilitate access to medicines in developing countries: A multi-country analysis of patients and patient outcomes in GIPAP;Kanavos;Global Health,2009
Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review;Current Pharmaceutical Design;2024-09
2. Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases;JBMR Plus;2024-02-24
3. Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort;British Journal of Haematology;2023-12-14
4. The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study;Blood Advances;2023-12-01
5. Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921;Journal of Clinical Oncology;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3